Roche - Stop Killing and Give Us Fuzeon!
Sign Now
Roche - Stop Killing and Give Us Fuzeon!
Fuzeon is an important part of combination treatment for people who have viruses that have become resistant to other available anti-HIV drugs. It was approved by the Korea Food & Drug Administration(KFDA) in May, 2004. However, the Swiss drug giant Roche has refused to supply the drug because of the failure of price negotiation with the government.
Roche has claimed $22,000 for the price of Fuzeon in South Korea. The yearly cost of $22,000 is double that of the most expensive HIV treatments existing in the market. And if considering that the drug must be taken in combination with other medicines, the total cost of treatment could reach between $30,000 and $40,000 per patient per year.
Roche is denying the access of people living with HIV/AIDS to the Fuzeon by charging unreasonably high price and even refusing to sell the drug in some countries including South Korea.
Access to treatment for infection with the human immunodeficiency virus (HIV) and AIDS has been problems in most countries and the spread of drug-resistant HIV has accelerated rapidly over the last several years. It is very critical for HIV patients to get access to proper medicines.
Roche's strategies on pricing and supply for Fuzeon has been threatening the lives of HIVpatients over the world as well as in South Korea. It is a crime against humanity. We urge Roche to stop abusing their power and supply Fuzeon at affordable price for every country where there are HIV/AIDS patients.
Fuzeon is an important part of combination treatment for people who have viruses that have become resistant to other available anti-HIV drugs. It was approved by the Korea Food & Drug Administration(KFDA) in May, 2004. However, the Swiss drug giant Roche has refused to supply the drug because of the failure of price negotiation with the government.
Roche has claimed $22,000 for the price of Fuzeon in South Korea. The yearly cost of $22,000 is double that of the most expensive HIV treatments existing in the market. And if considering that the drug must be taken in combination with other medicines, the total cost of treatment could reach between $30,000 and $40,000 per patient per year.
Roche is denying the access of people living with HIV/AIDS to the Fuzeon by charging unreasonably high price and even refusing to sell the drug in some countries including South Korea.
Access to treatment for infection with the human immunodeficiency virus (HIV) and AIDS has been problems in most countries and the spread of drug-resistant HIV has accelerated rapidly over the last several years. It is very critical for HIV patients to get access to proper medicines.
Roche's strategies on pricing and supply for Fuzeon has been threatening the lives of HIVpatients over the world as well as in South Korea. It is a crime against humanity. We urge Roche to stop abusing their power and supply Fuzeon at affordable price for every country where there are HIV/AIDS patients.
Sign The Petition
Continue with Google
OR
If you already have an account please sign in, otherwise register an account for free then sign the petition filling the fields below.
Email and password will be your account data, you will be able to sign other petitions after logging in.
Shoutbox
Goal
0 signatures
Goal: 50
Tags
No tags
Embed Codes
direct link
link for html
link for forum without title
link for forum with title
